Moxidrop-KT Eye Drop is a sterile, preserved-free, and pH-adjusted aqueous solution containing ketorolac tromethamine 0.4% w/v and moxifloxacin 0.5% w/v. This ophthalmic solution is designed to treat inflammation and reduce ocular pain in patients with postoperative ocular inflammation, including cataract surgery and conjunctivitis. The combination of ketorolac and moxifloxacin provides a synergistic effect in reducing inflammation and preventing bacterial infection. Ketorolac, a non-steroidal anti-inflammatory agent, effectively inhibits prostaglandin synthesis, thereby reducing inflammation and pain. Moxifloxacin, a fluoroquinolone antibiotic, selectively targets gram-positive and gram-negative bacteria, inhibiting DNA gyrase and topoisomerase IV, thereby preventing bacterial replication. Moxidrop-KT Eye Drop is administered as 1-2 drops in the affected eye(s) up to four times daily, with dosing intervals not to exceed 4 hours. The recommended duration of treatment is up to 14 days. Moxidrop-KT Eye Drop is contraindicated in patients with known hypersensitivity to either active ingredient.